dc.contributor.author | Azimaraghi, O | |
dc.contributor.author | Marashi, SM | |
dc.contributor.author | Khazaei, N | |
dc.contributor.author | Pourhassan, S | |
dc.contributor.author | Movafegh, A | |
dc.date.accessioned | 2018-08-26T09:38:30Z | |
dc.date.available | 2018-08-26T09:38:30Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58205 | |
dc.description.abstract | Background: Anesthesia induction in patients with current substance abuse can be a challenge for anesthesiologists. Objectives: This study aimed to evaluate the effect of adding Sufentanil to Bupivacaine on duration of brachial plexus nerve block. Patients and Methods: One hundred and twenty patients with (Groups C and D) and without (Groups A and B) a history of opium abuse (60 in each group) scheduled for elective upper extremity procedures were randomly assigned to either receive 30 mL bupivacaine alone (Groups A and C) or in combination with additional 10 ?g sufentanil (Groups B and D). An ultrasound-guided technique was applied to perform upper extremity brachial plexus blockade. The onset and duration of sensory and motor blocks were recorded and compared between the four groups. Results: The duration of sensory and motor block were significantly less in Group C (537.0 ± 40.1 minutes, 479.0 ± 34.8 minutes) and the longest duration of sensory and motor block was observed in group B (705.0 ± 43.8 minutes, 640.0 ± 32.5 minutes). The duration of sensory and motor block in Group B (705.0 ± 43.8 minutes, 640.0 ± 32.5 minutes) was longer and statistically higher than group A (619.5 ± 48.0 minutes, 573.2 ± 31.5 minutes), the same trend was observed in group D (598.6 ± 53.2 minutes, 569.3 ± 39.9 minutes) over group C (537.0 ± 40.1 minutes, 479.0 ± 34.8 minutes) (P < 0.001, one-way ANOVA). Conclusions: The length of sensory and motor blockade is shorter in chronic opioid abusers. Adding 10 ?g sufentanil to hyperbaric bupivacaine in opium abusers lengthened the sensory and motor block duration. © 2015, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). | |
dc.language.iso | English | |
dc.relation.ispartof | Anesthesiology and Pain Medicine | |
dc.subject | bupivacaine | |
dc.subject | diclofenac | |
dc.subject | lidocaine | |
dc.subject | paracetamol | |
dc.subject | placebo | |
dc.subject | sufentanil | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | brachial plexus anesthesia | |
dc.subject | controlled study | |
dc.subject | double blind procedure | |
dc.subject | echography | |
dc.subject | human | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | motor nerve block | |
dc.subject | nerve block | |
dc.subject | opiate addiction | |
dc.subject | randomized controlled trial | |
dc.subject | treatment duration | |
dc.subject | treatment outcome | |
dc.title | The effect of adding sufentanil to 0.5% hyperbaric bupivacaine on duration of brachial plexus blockade in chronic opium abusers: A randomized clinical trial | |
dc.type | Review | |
dc.citation.volume | 5 | |
dc.citation.issue | 3 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.5812/aapm.21960v2 | |